Latest Articles
I'm a women's health doctor- here are the period symptoms you should never ignore - Daily Mail
I'm a women's health doctor- here are the period symptoms you should never ignore Daily Mail
Published: June 24, 2024, 7 a.m.
Pain of Endometriosis: Bungoma woman's journey for diagnosis and treatment - The Star Kenya
Pain of Endometriosis: Bungoma woman's journey for diagnosis and treatment The Star Kenya
Published: June 24, 2024, 7 a.m.
Gloucester trains delayed after police incident - BBC.com
Gloucester trains delayed after police incident BBC.com
Published: June 22, 2024, 7 a.m.
New Hebron woman welcomes birth of triplets - Dailyleader
New Hebron woman welcomes birth of triplets Dailyleader
Published: June 22, 2024, 7 a.m.
Frontline Durvalumab/Chemo, Then Maintenance Durvalumab ± Olaparib, Improves ORR in Endometrial Cancer - OncLive
Frontline Durvalumab/Chemo, Then Maintenance Durvalumab ± Olaparib, Improves ORR in Endometrial Cancer OncLive
Published: June 21, 2024, 7 a.m.
Dr. Roach: Debilitating menstrual pain might be due to endometriosis - Detroit News
Dr. Roach: Debilitating menstrual pain might be due to endometriosis Detroit News
Published: June 18, 2024, 7 a.m.
AstraZeneca Imfinzi plus chemotherapy gets US nod for certain type of endometrial cancer - Reuters
AstraZeneca Imfinzi plus chemotherapy gets US nod for certain type of endometrial cancer Reuters
Published: June 17, 2024, 7 a.m.
AstraZeneca Imfinzi regimen for endometrial cancer gains FDA approval - Pharmaceutical Technology
AstraZeneca Imfinzi regimen for endometrial cancer gains FDA approval Pharmaceutical Technology
Published: June 17, 2024, 7 a.m.
FDA Approves AstraZeneca’s Imfinzi for Mismatch Repair Deficient Primary Advanced or Recurrent Endometrial Cancer - Pharmaceutical Executive
FDA Approves AstraZeneca’s Imfinzi for Mismatch Repair Deficient Primary Advanced or Recurrent Endometrial Cancer Pharmaceutical Executive
Published: June 17, 2024, 7 a.m.
Interleukin-1β induces and accelerates human endometrial stromal cell senescence and impairs decidualization via the c-Jun N-terminal kinase pathway | Cell Death Discovery - Nature.com
Interleukin-1β induces and accelerates human endometrial stromal cell senescence and impairs decidualization via the c-Jun N-terminal kinase pathway | Cell Death Discovery Nature.com
Published: June 15, 2024, 7 a.m.
Link copied to clipboard!